Holen Sie sich die Stockscreener-App
0.70
1.45%
-0.0103
Handel nachbörslich:
.70
Adagio Medical Holdings Inc Aktie (ADGM) Neueste Nachrichten
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance - Investing.com Canada
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance By Investing.com - Investing.com Australia
Adagio Medical Faces Nasdaq Minimum Bid Price Noncompliance - TipRanks
ADGM Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesSurprise Factor Analysis - newsline.com
Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Adagio Medical (NASDAQ: ADGM) flagged by Nasdaq for sub-$1 bid price and faces delisting risk - Stock Titan
ADGM Q1 2026 Earnings: Wider Loss Misses Estimates as Pre-Revenue Stage ContinuesQuarterly Earnings Report - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Losses Widen; No Revenue YetEarnings Preview - newsline.com
Adagio Medical Holdings Inc (ADGM) Q1 2026 Earnings: EPS Miss Exacerbates Investor Concerns as Pre-Revenue Company Confronts Cash BurnProfit Guidance Range - newsline.com
Adagio Medical Holdings (ADGM) Dips 3.3% as Shares Test Key Support at $0.68New Listing Stocks - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage ContinuesGuidance Accuracy Score - newsline.com
Lucid Capital Markets initiates Adagio Medical stock with buy rating - Investing.com UK
ADGM Initiates Coverage On LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus
Number of shareholders of Adagio Medical Holdings, Inc – NASDAQ:ADGM - TradingView
Lucid Capital Markets initiates Adagio Medical stock with buy rating By Investing.com - Investing.com Canada
Adagio Medical Seeks FDA OK for Heart Device - Orange County Business Journal
ADGM Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue OperationsRevenue Inflection Point - newsline.com
Adagio Medical Holdings (ADGM) Holds Near Support After Marginal DeclineRounding Bottom - newsline.com
Adagio Medical Holdings (ADGM) Holds Steady Near $0.72 as Trading Volume Remains SubduedNews Sentiment - newsline.com
Adagio Medical’s vCLAS System Used to Treat Premature Ventricular Contractions - Medical Product Outsourcing
ADGM Q1 2026 Earnings: EPS Misses Estimates, Shares Slide 10.8%Revenue Inflection Point - newsline.com
ADGM - Finviz
Adagio Medical Holdings (ADGM) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Development CostsProfitability Analysis - newsline.com
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - BioSpace
Adagio Files PMA for Breakthrough Ventricular Ablation System - TipRanks
Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system - Stock Titan
Adagio Medical submits FDA application for VT ablation system By Investing.com - Investing.com Nigeria
Adagio Medical submits FDA application for ventricular tachycardia ablation system - Medical Economics
Adagio Medical submits FDA application for VT ablation system - Investing.com
Adagio Medical submits premarket approval application to FDA for Vclas® ventricular ablation system - marketscreener.com
First purpose-built VT ablation system heads to FDA after 84% shock-free trial - Stock Titan
Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - Sahm
Perceptive Advisors (NASDAQ: ADGM) discloses 55.4% stake via Schedule 13G/A - Stock Titan
Adagio Medical Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TradingKey - TradingKey
Adagio Medical : BofA Securities 2026 Health Care Conference Presentation (9e4df6) - marketscreener.com
Adage Capital (ADGM) reports 1,258,501 shares, 5.67% stake - Stock Titan
Adagio Medical Holdings Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Adagio Medical Holdings, Inc. Q1 2026 10-Q Report: Financials, Risk Factors, and Forward-Looking Statements - Minichart
Adagio Medical Reports Strong Q1 2026 Results and Breakthrough FULCRUM-VT Trial Data for Ultra-Low Temperature Ablation Technology 1 - Minichart
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress - BioSpace
Adagio Medical Holdings, Inc. 1Q 2026: Revenue $5.2M, EPS ($0.31) — 10-Q Summary - TradingView
Adagio Medical (NASDAQ: ADGM) Q1 2026 loss, cash burn and going concern warning - Stock Titan
Adagio Medical Holdings Inc (ADGM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Adagio Medical Holdings (ADGM) price target decreased by 12.50% to 3.57 - MSN
Adagio Medical (ADGM) outlines 2026 director elections and auditor vote - Stock Titan
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference - BioSpace
Adagio Medical heart ablation system shows 84% freedom from shock - MSN
12 Health Care Stocks Moving In Monday's After-Market SessionAdagio Medical Holdings (NASDAQ:ADGM), Ad - Benzinga
Midday Stock Roundup: Willdan Group Drops 14% - Orange County Business Journal
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Adagio Medical’s vCLAS System Achieves 84% Freedom From Shock in Pivotal FULCRUM-VT Trial for Ventricular Tachycardia 1 - Minichart
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):